Ieq Capital LLC Makes New Investment in Phreesia, Inc. $PHR

Ieq Capital LLC purchased a new position in shares of Phreesia, Inc. (NYSE:PHR) in the 2nd quarter, Holdings Channel reports. The firm purchased 358,537 shares of the company’s stock, valued at approximately $3,689,000.

A number of other large investors also recently modified their holdings of PHR. EverSource Wealth Advisors LLC boosted its holdings in shares of Phreesia by 1,119.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after acquiring an additional 3,001 shares in the last quarter. Van ECK Associates Corp grew its position in Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after acquiring an additional 1,102 shares during the last quarter. New York State Teachers Retirement System acquired a new position in Phreesia in the 1st quarter worth about $44,000. Rockefeller Capital Management L.P. increased its holdings in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after purchasing an additional 2,149 shares in the last quarter. Finally, Allworth Financial LP bought a new position in Phreesia in the second quarter valued at about $58,000. 92.10% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

PHR has been the topic of a number of recent research reports. Piper Sandler lowered Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price target on the stock. in a research note on Thursday, May 28th. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research note on Friday, May 29th. Canaccord Genuity Group dropped their price objective on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating for the company in a report on Thursday, May 28th. Barclays reiterated an “equal weight” rating and set a $10.00 target price (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Finally, DA Davidson reissued a “buy” rating and set a $14.00 target price on shares of Phreesia in a report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $16.65.

Phreesia Trading Down 3.4%

NYSE PHR opened at $11.71 on Tuesday. The firm has a market capitalization of $723.86 million, a PE ratio of 78.07 and a beta of 0.85. The business’s 50-day moving average price is $10.83 and its two-hundred day moving average price is $10.50. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. Phreesia, Inc. has a 12 month low of $7.77 and a 12 month high of $32.76.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. The company had revenue of $130.94 million during the quarter, compared to the consensus estimate of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The firm’s revenue was up 12.9% compared to the same quarter last year. During the same period last year, the company earned ($0.07) earnings per share. On average, analysts expect that Phreesia, Inc. will post 0.39 EPS for the current year.

Phreesia Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.